RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR

RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR was reported 26 times

RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] 1 0.0004
2 Ergot Derivative [EPC] 2 0.0004
3 Tissue-nonspecific Alkaline Phosphatase [EPC] 4 0.0004
4 Interleukin-13 Antagonist [EPC] 1 0.0001
5 Interleukin-17A Antagonist [EPC] 3 0.0001
6 Nitrofuran Antibacterial [EPC] 1 0.0001
7 Integrin Receptor Antagonist [EPC] 3 0.0000
8 Thiazide-like Diuretic [EPC] 1 0.0000
9 Purine Antimetabolite [EPC] 2 0.0000
10 HER2/neu Receptor Antagonist [EPC] 1 0.0000
11 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
12 Kinase Inhibitor [EPC] 6 0.0000
13 Estrogen [EPC] 2 0.0000
14 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
15 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
16 Aromatase Inhibitor [EPC] 1 0.0000
17 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
18 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
19 alpha-Adrenergic Blocker [EPC] 1 0.0000
20 Microtubule Inhibitor [EPC] 1 0.0000
21 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
22 Interferon beta [EPC] 1 0.0000
23 Platelet Aggregation Inhibitor [EPC] 2 0.0000
24 Osmotic Laxative [EPC] 1 0.0000
25 beta-Adrenergic Blocker [EPC] 1 0.0000
26 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
27 GLP-1 Receptor Agonist [EPC] 1 0.0000
28 Corticosteroid [EPC] 2 0.0000
29 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
30 Benzodiazepine [EPC] 1 0.0000